Unió Europea -
danès -
EMA (European Medicines Agency)
eucreas
novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
Unió Europea -
danès -
EMA (European Medicines Agency)
zomarist
novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - narkotika anvendt i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
Unió Europea -
danès -
EMA (European Medicines Agency)
jentadueto
boehringer ingelheim international gmbh - linagliptin, metformin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - behandling af voksne patienter med type-2-diabetes mellitus:jentadueto er indiceret som et supplement til kost og motion til forbedring af glykæmisk kontrol hos voksne patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin alene, eller dem, der allerede behandles med en kombination af linagliptin og metformin. jentadueto er indiceret i kombination med sulphonylurea (jeg. triple kombinationsbehandling) som supplement til diæt og motion hos voksne patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea.
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "krka" 50+1000 mg filmovertrukne tabletter
krka d.d. novo mesto - metforminhydrochlorid, sitagliptin - filmovertrukne tabletter - 50+1000 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "sandoz" 50+1000 mg filmovertrukne tabletter
sandoz a/s - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+1000 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "stada" 50+850 mg filmovertrukne tabletter
stada arzneimittel ag - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+850 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "grindeks" 50+850 mg filmovertrukne tabletter
as grindeks - metforminhydrochlorid, sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50+850 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "glenmark" 50+1000 mg filmovertrukne tabletter
glenmark arzneimittel gmbh - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+1000 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "reddy" 50+850 mg filmovertrukne tabletter
reddy holding gmbh - metforminhydrochlorid, sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50+850 mg
Dinamarca -
danès -
Lægemiddelstyrelsen (Danish Medicines Agency)
sitagliptin/metformin "zentiva" 50+1000 mg filmovertrukne tabletter
zentiva k.s. - metforminhydrochlorid - filmovertrukne tabletter - 50+1000 mg